Related Experiment Video
Updated: Aug 12, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
First-in-Human Adjunctive Bacteriophage Therapy for Malakoplakia
Saima Aslam1, Aleah Brubaker2, Mita Shah3
1Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Abstract:
We report the first use of adjunctive bacteriophage therapy for Escherichia coli related malakoplakia in a kidney transplant recipient with progressive disease. Adjunctive CRISPR-enhanced phage cocktail SNIPR001 combined with prolonged antibiotics, ascorbic acid, and bethanechol was associated with cutaneous lesion resolution and sustained radiographic regression without phage-related adverse events.
More Related Videos
08:46T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Related Concept Videos
Lytic Cycle of Bacteriophages
Bacteriophages of the Human Virome
Lysogenic Cycle of Bacteriophages